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The results  obtained  by Marker and Volkert  (1)  from in vitro measurements  of 
the cell-mediated immunity to the lymphocytic choriomeningitis  (LCM) 1 virus have 
demonstrated  that  the  peak  of cytotoxic activity of lymphoid cells from  infected 
mice was reached  about 9 days after the inoculation  of virus.  This activity, how- 
ever, quickly vanished, and from the second or third week onward only traces of ceil- 
mediated  immunity to the virus  could be demonstrated.  These  results  agree  with 
data obtained in in vivo experiments by Minas and Blanden (2). These authors demon- 
strated  that lymphoid  ceils from  infected  mice 8 days after infection had a  strong 
antiviral  effect after  transfer  into infected  recipients,  whereas  cells harvested late 
in the infection were ineffective. On the other hand, both these groups of experimental 
results conflict with many observations obtained  by other techniques which strongly 
indicate  that the ceil-mediated immunity to the LCM virus is long lasting and plays 
an important role for the permanent immunity which follows the acute infection (3). 
However, the different results could have been dependent  on the different techniques 
used, and what has been observed might very well be due to qualitative  changes in 
the cell-mediated immunity during the various stages of infection. If this is so, a shift 
in the T-lymphocyte population responsible for the cell-mediated immunity probably 
also occurs. Such an idea would fit well with the evidence for the existence of a marked 
heterogeneity  among T  ceils, recently  obtained  by workers  in  other  fields of  im- 
munology (4-7). 
It was the purpose of the experiments presented in this paper to investigate 
these problems. Our results suggest that the T cells functioning during the acute 
state of the LCM infection in mice are distinctly different from those appearing 
at  a  later  stage.  Thus,  our  data  indicate  the  presence  of  two  functionally 
different subpopulations of T cells-each of which plays its own role in combat- 
ting the viral infection. 
Material and Methods 
M/ce.--Except for virus titration purposes highly inbred C~H mice were used throughout. 
Persistent tolerant virus carrier mice (virus carriers) were produced as described previously 
*This work was supported by grants from Statens l~egevidenskabelige Forskningsr£d. 
1Abbrev~ions used in this paper: LCM, lymphocytic choriomeningitis virus; PBS, phos- 
phate-buffered solution. 
2Lundstedt, C. Manuscript in preparation. 
3Monjan, A. A., and M. Volkert. Manuscript in preparation. 
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(8). These mice carried virus in high titers in blood and  organs and had no demonstrable 
immunity to the virus. 
Immune mice serving as donors were mice from either the early or the late state of the 
viral infection. The infection was initiated by i.p. inoculations of 103 LDs0 virus. Lymphoid 
cells representing the early immunity  (early immune cells) were harvested from the spleen 
and lymph nodes of mice infected 9 days previously, i.e., when the cytotoxic activity against 
infected target cells was maximal (1). Lymphoid cells representing the late immunity (late 
immune cells) were harvested from the same organs 30 days after the infection. At that time 
these cells after  transfer to  virus carriers  could  produce  a  strong adoptive immunization. 
Lymphoid  cells representing the  late  immunity were in  some  cases  also  harvested  from 
mothers of infected babies about 2 mo after the babies were born. These mice had undergone a 
natural infection and were solidly immune (9). The results obtained using the cells taken 30 
days after an i.p.  infection and those from  the immune mothers were  closely similar, and 
are therefore considered together. 
All donor mice were female mice aged 3-5 mo. The recipients of the cell transplants and 
their controls were also female C3H mice 3-5 mo old. They were chosen at random for  the 
experimental group, and no group consisted of less than eight mice. 
The LCM Virus.--The LCM virus originated from Dr. E. Traub  (Ludwig-Maximilians- 
Universitgt, Mfinchen, Germany). It was kept at  -70°C  as a  10% spleen suspension from 
i.p. infected C3H mice. The virus stock contained between 105 and 106 LDs0 virus. The virus 
titrations were carried out by i.c,  inoculation of ordinary 12-14 g  white  Swiss  mice.  Blood 
and organs from experimental mice were titrated individually. Titration end points were cal- 
culated by the Kttrber method (10).  Titers are expressed as log  10  LDs0/0.03  ml  i.c.  dose. 
In the figures the data recorded  are  the mean log  titers and  the standard  deviations cal- 
culated from the titration results. 
Anti-Theta Serum (AOS).--Anti-theta serum was supplied by Dr. Rubin (Statens Serumin- 
stitut, Copenhagen). It was produced by immunizing AKR mice with C3H mouse thymocytes. 
Undiluted serum and complement killed about 35% spleen cells and 55% lymph node cells  from 
Call mice but did not alter the number of plaque-forming cells in a  spleen cell population 
containing antibody-forming cells against sheep  erythrocytes.  Undiluted serum  in  the ab- 
sence of complement did not change the viability of either spleen or lymph node cells from 
C3H mice. The data obtained thus strongly indicated that the cytotoxicity of the serum was 
T-cell specific. In all experiments described in this paper, serum dilutions of 1 : 2 were employed. 
The lymphoid cells in amounts of 2-5  X  10  s were incubated in the serum at 4°C for 1 h. 
Then the cells were separated out by gentle centrifugation and resuspended in tissue culture 
medium containing appropriate amounts of guinea pig complement. After 45-min incubation 
at 37°C the cells were either transplanted or tested for cytotoxicity. Cell batches used as con- 
trols were prepared and treated in exactly the same way except that the anti-theta serum was 
replaced  by tissue culture medium. 
X-Ray Irradiation.--X-ray  irradiation was administrated by a Siemens Stabllipan therapy 
machine operated at 200 kV and 15 mA with 0.9 mm Cu and 0.5 mm AI filtration (half-value 
layer equal to 1.5 mm Cu). The cells were irradiated, suspended in phosphate-buffered solu- 
tion (PBS)  (10  X  106 cells per ml), and placed in petri dishes with a  diameter of  4.5  cm 
(4-ml suspension per dish). 
Itistology.--Drop-smears  from  suspensions  of  lymphoid  cells  were  stained  with  May- 
Grtinwald-Giemsa after fixation with methanol. 
The complement fixation (CF) test, the cytotoxic assay,  the calculation  of  the  cytotoxic 
indices and  the preparation  of lymphoid cell suspensions were carried out by the methods 
described previously (1). In all experiments mixtures of spleen and lymph node ceils were em- 
ployed. 
The  adoptive immunization of  virus carriers was  carried  out by i.p.  inoculations  (11). 
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purpose of protecting infected mice were carried out by i.v. inoculation. The volumes given 
were 0.5 ml. 
RESULTS 
The  Possible  Role  of  Enhancing  Substances  for  the  Disappearance  of  the 
Cytotoxic Lymphocytes  During  the Acute  Infection.--In  Marker  and Volkert's 
experiments the disappearance of the cytotoxic lymphocytes from the spleen 
and lymph nodes of infected mice coincided with the appearance of antibodies. 
The  possibility  that  these  antibodies  or  complexes  of  antibodies  and  viral 
antigen could function as blocking substances and thereby mask the presence 
of cytotoxic cells could therefore not be excluded.  This type of inhibition  of 
cytotoxicity could conceivably work in two ways: (a) the blocking substances 
could have influenced the cytotoxic cells in vivo, and (b)  antibodies produced 
in vitro by the  suspended  spleen  and lymph node cells during  the  18  h  test 
could block the receptors on the infected target cells. 
To test the  first possibility cytotoxically active lymphoid cells from  mice 
infected 9 days previously were incubated with  serum from immune mice.  In 
two  experiments  the  serum was  harvested  14  days  after  the  inoculation  of 
virus, at a time when the antibodies had reached a titer level of 64, while the 
cytotoxicity of the spleen and lymph node cells had diminished considerably. 
In two other experiments the serum employed was harvested 28 days after the 
infection, i.e.,  at a  time when the cytotoxic cell activity was zero. The serum 
was used in a dilution of 1:4.  1 ml of this dilution was mixed with 17.6 X  106 
cells and incubated at 37°C for 30 rain. After washing twice in PBS the cells 
were tested for cytotoxicity. Lymphoid cells incubated with normal serum and 
washed  twice with PBS  were used  as controls.  The  results  are presented  in 
Table I. It is apparent that the treatment with immune serum did not change 
the cytotoxic effect. 
To test the  other possibility the  target cells were incubated with immune 
serum. The serum batches used were the same as in the experiment described 
above. In each case the serum in a dilution of 1 : 4 was poured over the infected 
target cells which had been washed  twice with PBS  and were ready for the 
cytotoxic test. 0.4 ml of the serum dilution was employed per petri dish  and 
the incubation took place at 37°C  for 30 rain. The cytotoxic assay was then 
carried out in the usual way using lymphoid cells from mice 9 days after the 
infection. The serum used for incubating was left on the cells throughout  the 
test.  Target cells incubated with normal serum in  the same dilution  and for 
the same period as used for the immune serum served as controls. The results 
are also recorded in Table I, and reveal that no blocking substance could be 
demonstrated in the immune serum. 
The Size of the Spleen and Lymph Node Cells from Infected Mice.--Andersson 
(12)  has  reported  that  the  size  of  cytotoxic  effector  cells  in  mice  changed 
during  the  immune  response  to mastocytoma cells.  For  this  reason  the  cell 1332  IMMUNITY  TO  LYMPHOCYTIC  CtIORIOMENINGITIS VIRUS 
TABLE I 
Effect of Immune Serum on the Cytotoxic Reaction baween Early Immune lymphoid Cells and 
LCM Vires-Infected  Target Cdls 
Cells  incubated  Serum used for 
with serum  incubation* 
Cytotoxic index 4- SD 
Exp. 1  Exp. 2  Exp. 3  Exp. 4 
Effectorcells  Normalserum  18.5  4-  1.7  78.6  4- 4.5 
"  "  14-dayserum  22.3  +  3.6  74.1  ±  4.1 
"  "  28-day serum 
Target cells  Normal serum  24.6  4- 3.4  78.3  4-  5.2 
"  "  14-dayserum  30.1  +  2.2  75.8  4- 2.9 
"  "  28-day serum 
40.4  4-  7.8  86.8  4- 3.4 
43.0  4- 3.2  80.5  ±  3.1 
54.9  -4- 3.7  64.7  ::J= 3.3 
54.0  4- 6.4  66.7  4-  1.7 
* Pools of sera obtained from groups of normal mice and from groups of mice inoculated 
i.p. with 103 LDs0 of virus 14 or 28 days previously. For each of the three types of sera two 
different pools were tested. 
size of the ceils in the populations employed by us was investigated.  Our find- 
ings were in agreement with Andersson. In the early immune state to the LCM 
infection the cell mixtures from the spleen and lymph nodes contained 30-35 % 
large  and  blastlike  lymphocytes, whereas  the  cell  mixtures  harvested  during 
the late immune state contained only 10-15 % of these cells. 
The  Change in  Function of the Lymphoid  Cells from  Infected Mice.- 
The effect on the acute infection:  As mentioned in the introduction, Mires and 
Blanden  have  already  shown  that  an  antiviral  effect of lymphoid cells  after 
transfer  to  infected  recipients  could  be  observed with  cells  harvested  in  the 
early immune  state.  In  this  laboratory  these  observations  were  readily  con- 
firmed. In our experiments doses of 100 )<  106 early immune cells were able to 
reduce the virus titers in the liver and the spleen after transfer  to acutely in- 
fected  recipients.  Moreover,  the  results  of transplantation  experiments  with 
cells harvested late in the infection were much less pronounced. 
On  the  basis  of these  results  it  seemed  appropriate  to investigate  whether 
transplanted  lymphoid cells  could influence  the  clinical  outcome of an LCM 
infection. For this purpose groups of mice were infected i.c. by 103 LDs0 virus 
and then given transplants  of spleen  and lymph node cells from infected mice. 
The  experimental  set up  and  the  results  are  recorded in Table  II. It can be 
seen that if 100  >(  106 early immune cells are transplanted  on the day of the 
infection, the lives of all  the recipients are saved. If the cells are given 2 days 
later most but not all recipients survive, and if the transplantations were post- 
poned for 4 days 19 out of 21 mice died.  Moreover, a  small cell dose of 25  )< 
l0 s was  also effective.  However,  large doses of late  immune  cells had  only a 
little  life-saving capacity even if the  cells were transplanted  on the  day that 
the recipients were infected. 
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TABLE  II 
Effect of Immune Lymphoid Cells after Transfer to Acutely Infected Mice* 
1333 
Cell  source  Cell  dose  Time of transfer 
Protectlon~; 
Exp. 1  Exp. 2 
--  None  --  0/10  0/12 
Early imm. cells  100  X  106  Day of inf.  9/9  12/12 
"  25  X  106  Day of inf.  10/10  12/12 
"  100  X  10 ~  2 days after inf.  5/8  9/11 
"  100  X  106  4 days after inf.  1/9  1/12 
Late imm. cells  100  X  106  Day of inf.  3/10  0/12 
* Inoculated i.c. with 10  3 LDs0 of LCM virus. 
Proportion of mice surviving virus inoculation (observation time 14 days). 
one another. Both strongly indicate that during the infection a change occcurs 
in the functional capacity of the spleen and lymph node cells of the infected 
mice. 
The  effect  on  the  persistent  tolerant  infection:  Previous  experiments  by 
Volkert and his co-workers (9, 11, 13) have demonstrated that lymphoid cells 
from infected mice could also cause a violent adoptive immunization in mice 
with a persistent tolerant LCM viral infection. In view of the findings described 
above it is, however, surprising that this adoptive immunization was brought 
about with cell transplants  originating from mice infected a  month or more 
before the cells were harvested. Moreover, data were also obtained (11) which 
indicated that, with respect to their ability to confer an adoptive immunity, 
the cells from mice late in the infection were superior to those taken from mice 
in an earlier state. Because of these observations the ability of lymphoid cells 
to confer an adoptive immunization was investigated. 
Virus  carriers served as  recipients of the  cell transplants.  Three kinds  of 
donors were employed. The first consisted of mice at the early state of immunity, 
the second of mice at the late state, and the third of normal mice. The donors 
were grouped in accordance with their immune state and within each group 
suspensions of pooled spleen and lymph node cells were prepared and trans- 
planted  i.p.  in  amounts  of  100  X  l0  s cells per  recipient. Before the  trans- 
plantation and 10 and 20 days afterwards, the blood virus titers of the trans- 
planted  mice  were  determined.  Two  experiments were  carried  out  and  the 
results were almost identical.  The data from one of the experiments are re- 
corded in Fig. 1. It is apparent that the lymphoid cells from mice in the late 
state of immunity could, as expected, confer a strong adoptive immunization, 
demonstrable  by  the  pronounced  antiviral  effect of  the  transplanted  cells. 
However, the  cells from the  donors  at  the  early state  of immunity had  so 
modest an antiviral effect that it was hardly detectable. The results obtained 
thus once again revealed the difference between the lymphoid cells from mice 1334  IMMUNITY  TO  LYMPHOCYTIC  CHORIOMENINGITIS  VIRUS 
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FIG. 1.  The blood virus fiters of virus carrier mice after receiving transplants of 100 )< 
10 ~ early immune cells (©--0), late immune cells (X--X), or normal cells (/k--A). 
in  the early and the late  state  of immunity.  In this  case,  however,  the  cells 
from the late state were greatly superior to the others. 
The effect of X  irradiation:  It is well  known that X  irradiation can cause 
destruction  of lymphocytes or inhibition  of their  function.  It is  also known 
that the susceptibility to X  irradiation varies considerably among the different 
lymphocytes. It therefore seemed possible to use X  irradiation as an additional 
means of differentiating between the early and the late LCM immune cells. In 
attempts  to do this,  batches of early and  late  immune cells  were  irradiated 
with  300,  600,  or 900  R.  The  function of  the  early immune  cells  was  then 
tested by the cytotoxic assay and by their ability, after transfer to mice on the 
day of an i.c.  infection, to protect against a  lethal infection. The function of 
the  late  immune  cells  was  tested  in  adoptive  immunization  experiments  in 
virus carriers. 
The effect on the early immune cells is recorded in the first part of Tables 
III and IV. Concerning the cytotoxic effect,  it can be seen that in one experi- 
ment no reduction could be observed even after treatment with 900 R. In the 
other experiment 300 R  caused a modest decrease but 600 R  and 900 R caused 
no further reduction and a considerable cell activity remained. Concerning the 
ability to protect against a lethal infection, 300 R  and 600 R  had no influence 
and even 900 R  could not completely abolish this cell function. 
The  effect on  the  late  immune  cells  was  tested  in  two  experiments.  The MOGENS VOLKERT, OLE MARKER, AND  KLA'US  BRO-J~RGENSEN  1335 
TABLE nI 
Influence of X  Irradiation  and of Anti-Theta Serum Treatment on the Cytotoxic Effect of Early 
Immune Cells 
Treatment of lymphoid cells  Lymphoid cells 
per target cell 
Cytotoxic index 
Exp. 1  Exp. 2 
None  25  38  4-  2.1  77  4-  2.2 
None  12,5  21  -4- 0.3  48  4-  1.4 
None  6.25  10  4-  0.2  24  4-  1.4 
300 R of X rays  25  37  4- 0.2  57  4- 4.9 
600 R of X rays  25  34  4-  1.1  52  4-  2.2 
900 R of X rays  25  34  4- 1.9  56  4-  2.0 
Incubation with anti-0 serum  25  0.9  4-  1.2  3.3  4-  0.7 
Sham incubation  25  23  4-  1.4  33  4-  1.0 
TABLE IV 
Influence of X  Irradiation  and of Anti-Theta Serum Treatment on the Protective Effect of Early 
Immune Cells 
Treatment of lymphoid cells  Cell dose 
Protection* 
Exp. 1  Exp. 2 
--  None  0/10  0/10 
None  100  X  100  10/10  10/10 
300 R of X-rays  100  X  10 °  10/10  10/10 
600 R of X-rays  100  X  106  10/10  10/10 
900 R of X-rays  100  X  106  3/10  4/10 
Incubation  with anti-0 serum  100  X  106  3/10  0/10 
Sham incubation  100  X  106  10/10  10/10 
* Proportion  of mice surviving i.c. inoculation with 108 LDso of LCM virus. Cells were 
transplanted on the day of the infection. 
results obtained were very similar to one  another and the data from the first 
experiments are recorded in Fig. 2. All cells employed in each test originated 
from the same cell batch. The adoptive immunization with the untreated con- 
trol cells was carried out with 25  X  10 e cells, while the X-irradiated cells were 
transplanted in doses of 100 X  106. The blood virus titers of the recipients were 
investigated before transplantation and 10 and 20 days afterwards. The virus 
titer curves reveal that 100  X  106 cells irradiated with only 300 R  were less 
effective than 25 X  106 untreated cells, i.e., the cell effect was reduced by more 
than 75 %. The cells which had received 600 R  had an antiviral activity com- 
parable to that which had been demonstrated many times in this laboratory 
by doses of 10-15 X  106 untreated cells. 900 R  completely abolished the ability 
of  the  cells to influence the virus in the recipient virus carriers. The results 
obtained thus revealed that the  early  and  the  late  immune cells  also  differ 
considerably with respect to their susceptibility to X  rays. 1336  IMMUNITY  TO  LYMPHOCYTIC  CHORIOMENINGITIS  VIRUS 
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FIo. 2.  The blood virus titers of virus carrier mice after receiving transplants  of 100 X 
106 X-irradiated  late immune cells; 300 R  (0--0), 600 R  (A--A), 900 R  (O--Q). Con- 
trols received 25 X  106 nonirradiated  late immune cells (X--X). 
The effect  of anti-theta serum treatment:  As  mentioned  in  the  introduction 
the  available  data  strongly  indicate  that  cell-mediated  immunity  plays  an 
important role in the early as well as in the late immunity to the LCM virus. 
Probably, therefore, T  lymphocytes are active in both these states of immunity 
and what we have measured in our tests has been T-cell activity. To test this 
hypothesis  the  effect  of  anti-theta  serum  treatment  was  investigated.  After 
the treatment the early immune cells were tested in the cytotoxic assay and for 
their  ability,  after transfer to mice on the day of an i.c. infection,  to protect 
against a  lethal infection. The function of the late immune cells was tested in 
adoptive immunization experiments  on virus carriers.  The effect on the early 
immune cells is recorded in the second part of Tables II[ and IV. It appears 
that  anti-theta  serum  can completely abolish  all  cytotoxic activity and  con- 
siderably reduce the protective effect against a lethal infection. 
The anti-theta  serum effect on the late  immune cells is recorded in Fig. 3. 
The cells used for transplantation  were all from the same cell batch.  The un- 
treated  control cells were  transplanted  to virus  carriers  in amounts  of 25  X 
l0 s,  other  control  cells  which  had  undergone  the  same manipulations  as  the 
experimental  ones  except  for  the  omission  of  anti-theta  serum  were  trans- 
planted  in  amounts  of  100  X  106, and  the  same  was  the  case  for  the  cells 
which had undergone  the  anti-theta  serum  treatment.  The virus  titer  curves MOGENS  VOLKERT,  OLE  MARKER,  AND  KLAUS  BRO-J¢I~GENSEN  1337 
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F]o. 3.  The blood virus titers of virus carrier mice after receiving transplants of 100 X  l0 s 
anti-theta  serum-treated  (O--O)  or  sham-treated  (A--/X)  late  immune cells. Controls 
received 25 X 106 nontre~ted late immune cells (X--X). 
reveal that the transplant of 100  X  108 anti-theta serum-treated cells was less 
active than the transplant of 100  X  l0 s control cells, and also less active than 
25  X  l0 s untreated cells.  Thus, the anti-theta serum experiments support the 
assumption that both early and late immune cells belong to the T-lymphocyte 
population. 
DISCUSSION 
Table V summarizes the results described in this paper. Where the difference 
in  the size distribution  of the lymphoid cells in the  spleen and lymph nodes 
during the early and the late immune state to the LCM virus is concerned, our 
results correspond to those obtained by Shortman et al.  (14)  and Andersson 
(12)  in allograft immunity experiments. Where the cytotoxicity is concerned, 
most workers seem to agree that it is the large blastlike cells which are the real 
killer cells,  and this could correspond to the observation made by us and others 
that it is at the time at which these cells are most numerous that the cytotoxic 
activity of the cell population is at its peak. On the other hand, it is also well 
known  that  the blast cells can develop from small lymphocytes. Apparently 
few blast cells in a cell mixture used, therefore, do not imply that it is cytotoxi- 
cally inactive. Accordingly, morphological studies cannot give any definite an- 
swer concerning the cytotoxic action of a cell mixture, but the presence of many 1338  IMMIYNITY TO LYMPHOCYTIC CHORIOMENINGITIS  VIRUS 
TABLE V 
T Lymphocytes  Immune to the LCM Virus 
Cell criteria  Early immune  cells  Late immune  cells 
Cell size  30-35% large  10-15% large 
Cytotoxic activity  + + + +  (+) 
Antiviral activity in acute inf.  ++++  + 
Protection  against lethal inf.  4-+4-+  + 
Adoptive immunization of virus carriers  4-  4- + + 4- 
Resistance to X rays  4- 4- + +  + 
Susceptibility to anti-O serum  + 4- +  4- 4- 4- 
large blastlike cells might indicate a strong cytotoxic activity. The relation of 
cell size to the other functions of the immune lymphoid cells described in this 
paper is completely unknown. 
The rise and fall of cytotoxic activity of the cell populations in the spleen 
and lymph nodes during  the different states of immunity to  the LCM virus 
has been described in a previous paper from this laboratory (1). In the discussion 
of this presentation it was pointed out that it was very surprising that the cell 
activity vanished  so  quickly  and  that  this was probably not merely a  local 
organ phenomenon.  Moreover,  in  the  experiments described in  this paper it 
has not been possible to demonstrate the presence of any blocking or inhibitory 
substances in the blood at the time when the cytotoxic activity was in a sharp 
decline,  nor  later when  all  the  activity had  disappeared.  Nevertheless it  is 
striking that the cytotoxic activity of the cells from the spleen and the lymph 
nodes vanishes at the time that viral antibodies begin to appear. It is therefore 
tempting to put forward the hypothesis that these antibodies are in some way 
involved in the phenomenon. However, in view of our results it seems unlikely 
that the antibodies themselves or the antigen-antibody complex produced by 
them have any direct influence on the active lymphoid cells or on the target 
cells. It therefore seems more probable that if antibodies do have a depressive 
effect on the cellular immunity it is an afferent or central effect on the develop- 
ment of cytotoxic cells.  If this is the case, and if as assumed the disappearance 
of active cells is not only a  local organ phenomenon,  then our findings might 
indicate that the cytotoxic cells have a  short life span and die out. We shall 
return to this point later in the discussion. 
The anti-LCM viral activity of early immune cells in acutely infected mice 
described by Mires and Blanden  (2)  was readily confirmed by us.  Moreover, 
our findings that the cells from the early state after transfer to infected mice 
could  protect  against  a  lethal  infection  correspond  to  and  extend  these  ob- 
servations. However, Gilden et al.  (15)  have clearly shown that the early im- 
mune cells can also kill the animal, but most probably the cell activity is lethal 
only when certain specific conditions are fulfilled. The data obtained by us and 
by others (1, 3, 15-17, footnotes 2, 3) indicate a hypothesis which suggests that MOGENS VOLKERT, OLE  MARKER, AND  KLAUS BRO-J~RGENSEN  1339 
to kill the animal the cytotoxic cells must be present in sufficient numbers at a 
time when the virus has reached high titers and has been concentrated in a 
delicate organ such as the choriomeningeal plexus. If this happens,  and that 
is the case after a lethal i.c. infection (or the situation can be induced by trans- 
plants of cytotoxic cells at the right time to immunodepressed infected mice), 
then the animal cannot survive the damage caused by the cytotoxic cells on 
the infected target cells.  If, however, after i.c. inoculations of small doses of 
virus, a sufficient number of cytotoxic cells to check the virus develop before 
too many meningeal cells are infected, the damage done by the immune attack 
is not great enough to be lethal. With our strain of virus the same situation 
occurs after an i.p. infection. In this case the virus reaches the meninges late 
and will not be concentrated, nor reach high titers in this organ before the im- 
mune attack  is mounted.  The animal  will,  therefore, survive.  On  the  other 
hand  if,  during  an i.c.  infection, the  cytotoxic cells develop late,  the virus, 
which is not in itself cytotoxic, will  continue to grow uncontrolled for some 
time, the infection will  spread to other organs and moreover the infection in 
the choriorneningeal plexus will  diminish.  This is the situation late after an 
immunodepressive treatment of acutely infected mice, and it is also the situa- 
tion after infections of newborn mice. In these cases we know that the animal 
will  survive the infection and we also know that it will survive transplants of 
cytotoxic cells.  Probably as was the case in the i.p. infections the cell attack 
when it develops or is induced by transplants  will  be too dispersed and not 
sufficiently concentrated on vital organs to cause lethal damage. 
Data  obtained previously by Marker  and Volkert  (1),  indicate  that  late 
immune cells can to some extent convert to cytotoxic cells. This seems contrary 
to the observations described in this paper which indicate that late immune 
cells,  after transfer to infected mice, have little effect on the outcome of an 
acute infection. However, these last results are in agreement with the experi- 
ments carried out by Mires and Blanden (2)  and by ourselves, which indicate 
that the late immune cells also have a very poor antiviral effect after transfer 
to acutely infected mice. Probably, therefore, in transplanted, acutely infected 
mice, the conversion of the late immune cells to active cells takes too long, or 
too few cells are converted, to give a sufficiently rapid retardation of the growth 
of the virus to save the lives of the animals. 
In  the  adoptive immunity experiments on virus  carriers it  was  also,  and 
exclusively, the antiviral effect of the transplanted cells which was chosen as 
a parameter for cell activity. The humoral response, because of its dependence 
of B  lymphocytes, was not taken into account. The results obtained demon- 
strated very clearly that  the  cells from the late immune  state had an  anti- 
viral effect after transfer to the chronically infected virus carriers, whereas the 
early immune cells were much less effective. Even a  very high dose of early 
immune cells had only a  slight influence on the blood virus titers of the re- 
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tained  when  early and late immune cells  are transferred  to  acutely infected 
mice,  and indicate  a  striking functional difference between  the  two kinds  of 
cells.  Moreover, in  the  acutely infected mouse it seemed quite  reasonable to 
consider the cells which developed in the early immune state as precursors of 
those which developed later. If this were the case it seemed logical to assume 
that  the  early immune  cells  after  transfer  to  virus  carriers  would  by  time 
convert to late immune cells and thereby achieve the same antiviral effect in 
the carrier mice as the ordinary late immune cells. This was not the case, and it 
therefore seems hard  to  believe  that  the  cell mixture  of early immune  cells 
contains more than a few precursors of the antiviral cells in the late immune 
state. This means that the many cells which have an antiviral activity during 
the acute infection most probably do not convert to the cells which are anti- 
viral in the chronic infection. Thus the data obtained give further support to 
the assumption mentioned above that the early immune cells with an antiviral 
activity are end cells. 
It is well known that the X  irradiation primarily causes damage to the cell 
mitoses.  The  fact  that  the  function  of  early  immune  cells  was  difficult  to 
destroy by X  irradiation therefore indicates that the activity of these cells in 
our test system is not dependent on cell division but  that it is a  quality ac- 
quired before the cells were harvested from the donors. Furthermore, the rela- 
tive ease with which X  irradiation  can damage the function  of the  late im- 
mune cells indicates that these are dependent on cell division before they ac- 
quire sufficient antiviral activity to influence the virus when transferred to virus 
carrier mice.  Our  results  resemble  the  data  obtained  in  allograft  immunity 
experiments by Denham et al. (18)  and by Stobo et al. (4)  and we agree with 
these authors that the difference in X-ray sensitivity of T cells indicated that the 
cells tested belong to two different cell populations. As pointed out above, the 
results  from all  the  other  experiments  described  in  this  report  support  this 
assumption. 
Concerning the classification of the active lymphocytes which develop during 
the different states of immunity to the LCM virus, Mires and Blanden (2) have 
presented a few data which indicate that the antiviral activity of early immune 
cells was T-cell dependent, and Cole et al. (19, 20) claim that they have been 
able to influence  the  cytotoxic activity by treatment with  anti-theta  serum. 
Our anti-theta experiments confirmed that this serum could abolish cytotoxic 
activity of  early  immune  cells.  However,  the  low  cytotoxic index  obtained 
by the control cells which had undergone the same physical manipulations as 
the  anti-theta  serum-treated  cells  indicates  that  the  manipulation  itself  is 
rather harmful. Whether or not the anti-theta serum could abolish all or only 
some of the activity originally present in the fresh cell mixture is, therefore, 
not known. Anti-theta serum has, in our experiments, also been able to cause a 
considerable reduction in the ability of early immune cells to protect against a 
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cells their ability to cause an adoptive immunization of virus carriers was re- 
duced by at least 80-85 %. Both the early and the late immune cell popula- 
tions accordingly contain a large percentage of anti-theta serum sensitive cells 
among the cells which are active in our assay systems. These cells are therefore 
probably T  cells. However, further criteria for the T-cell classification of these 
cells are desirable, and attempts to obtain such are in progress in our labora- 
tory. As the anti-theta serum treatment in our experiments did not completely 
abolish the cell activity, the experiments in progress are also aimed at elucidat- 
ing the possible role played by lymphocytes that do not belong to the T-cell 
population. 
The probable role of the early immune T  cells has been discussed above, and 
it has been shown that these cells have little influence on the virus in chronically 
infected virus  carriers. However, an  antiviral  effect in  these mice is  readily 
demonstrable when late immune T  cells are transplanted to them. Probably, 
therefore, the  late immune  cells  are  specially  suited  to work in  chronically 
infected animals. It seems tempting to postulate that these are the cells which 
eliminate remnants of virus which might be left over after the early immune 
cells have done their job during the early phase of the infection. Moreover, 
in agreement with the other data mentioned in the introduction of this paper, 
it seems reasonable to suggest that it is the late immune T  cells which play the 
most important role for the surveillance of the occult virus which often per- 
sists  after an  acute LCM  infection in mice. The mechanism by which  they 
accomplish this is, however, not known. 
SUMMARY 
In this report seven different parameters were employed to investigate the 
spleen and lymph node cells from mice at the early and the late state of im- 
munity to the lymphocytic choriomeningitis (LCM) virus. Distinct differences 
were observed. Morphological studies revealed a  different size distribution of 
the cells in the preparations from the early and the late state of immunity. 
The cell mixtures of early immune cells contained many more large and blast- 
like lymphoid cells than the other. Where the cell function was concerned, the 
cytotoxic activity against LCM virus-infected target cells was almost entirely a 
function of the  early immune cells,  and our data strongly indicate that  en- 
hancement does not play any role for the disappearance by time of this cell 
activity. The antiviral effect after transfer to acutely infected animals was also 
predominantly a function of the early immune cells and the same was the case 
concerning the ability to protect against a lethal acute infection. However, the 
early immune cells were almost inactive after transfer to chronically infected 
virus carriers, whereas transplants of late immune cells to such mice had a very 
strong antiviral effect. The resistance to X  irradiation also varied. Even high 
X-ray doses could not destroy the function of early immune cells, whereas the 
function of the late immune cells was  readily impaired by X-ray treatment. 1342  IMMUNITY  TO  LYMPHOCYTIC  CHORIOMENINGITIS  VIRUS 
The early and the late immune cells have one thing in common--both are sus- 
ceptible to treatment with anti-theta serum. Because of the differences observed 
between the early and the late immune cells, it is concluded that they belong 
to different  cell populations.  However,  because  of the  common susceptibility 
to anti-theta  serum,  probably both populations  are T-cell  lymphocytes. The 
implications  of  the  results  and  the  role  of the  different  cells  in  the  combat 
of the viral  infection are discussed. 
The authors thank Dr. B. Rubin for the supply of anti-theta serum, and we are grateful to 
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